The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.
Frequently asked questions
What is the Fidelity Disruptive Medicine ETF (FMED) expense ratio?
The Fidelity Disruptive Medicine ETF funds expense ratio is 0.5%.
What is Fidelity Disruptive Medicine ETF (FMED) current stock price?
As of the latest data, Fidelity Disruptive Medicine ETF stock price is $32.66, with a previous close of $32.31. Fidelity Disruptive Medicine ETF gained $0.35 in the last trading session, representing a 1.09% increase.
Does Fidelity Disruptive Medicine ETF (FMED) pay dividends?
No. Fidelity Disruptive Medicine ETF does not pay a dividend.